In 2015, Spinifex was acquired by Novartis for a US$200m upfront payment and significant further milestone payments.

Melbourne based Spinifex Pharmaceuticals Pty Ltd is a private company established in June 2005 to undertake drug development activities leading to the commercialisation of potential new drug candidates for the treatment and management of pain.